| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 2.15× | 2.15× | 1.52× | 4.48× | 2.54× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.00× | 0.00× | 0.01× | 0.01× | 0.02× | ||
| 0.95× | 0.95× | 0.86× | 0.19× | 0.84× | ||
| 0.85× | 0.85× | 0.72× | 0.19× | 0.69× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 2.54 | 4.48 | 1.52 | 2.15 | 2.15 | |
| Asset Turnover | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | |
| Cash Conversion (CFO/Net Income) | 0.84 | 0.19 | 0.86 | 0.95 | 0.95 | |
| CFO/EBITDA | 0.69 | 0.19 | 0.72 | 0.85 | 0.85 |